Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Escitalopram oxalate
Drug ID BADD_D00810
Description Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]
Indications and Usage Escitalopram is indicated for both acute and maintenance treatment of major depressive disorder (MDD) and for the acute treatment of generalized anxiety disorder (GAD).[L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]
Marketing Status approved
ATC Code N06AB10
DrugBank ID DB01175
KEGG ID D02567
MeSH ID D000089983
PubChem ID 146571
TTD Drug ID D08RBC
NDC Product Code 82009-036; 58032-0134; 65015-886; 50090-6025; 65862-248; 65862-373; 68071-3265; 68084-618; 70934-060; 71205-792; 0615-8475; 68788-8371; 0904-6427; 68554-0136; 16571-769; 42708-077; 45865-996; 55700-993; 65162-019; 70518-1291; 68001-195; 68001-196; 0615-8477; 82009-037; 0456-2021; 55111-944; 71052-647; 50090-6496; 55154-6893; 63629-2981; 63629-8042; 70518-0791; 82009-035; 45562-1130; 68554-0007; 13668-135; 43063-761; 50090-6023; 65162-021; 71205-193; 71335-9687; 0615-8476; 82982-065; 53104-7565; 70966-0032; 72761-009; 51655-147; 65862-375; 68084-617; 0456-2006; 65372-1116; 65691-0066; 13668-136; 31722-569; 55154-7288; 72789-311; 51686-0011; 64220-109; 65862-411; 50090-1279; 51672-1348; 61919-139; 65862-374; 68001-197; 71205-168; 71335-0685; 0904-6426; 0456-2011; 13668-137; 65162-020; 71205-313; 71335-0658; 65372-1143
UNII 5U85DBW7LO
Synonyms Escitalopram | Escitalopram Oxalate | Lexapro
Chemical Information
Molecular Formula C22H23FN2O5
CAS Registry Number 219861-08-2
SMILES CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Suicide attempt19.12.01.004--
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Tachycardia02.03.02.007--Not Available
Tardive dyskinesia17.01.02.012--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombosis24.01.01.006--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Toothache07.09.06.001--
Torsade de pointes02.03.04.005--Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Urinary tract infection20.08.02.001; 11.01.14.004--
Urticaria23.04.02.001; 10.01.06.001--
Ventricular arrhythmia02.03.04.006--
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.10.013--Not Available
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Yawning22.12.03.037--Not Available
Deep vein thrombosis24.01.02.003--Not Available
Self-injurious ideation19.12.01.007--Not Available
Thoracic operation25.13.05.001--Not Available
Musculoskeletal stiffness15.03.05.027--Not Available
Inappropriate antidiuretic hormone secretion14.05.07.001; 05.03.03.001--Not Available
Weight abnormal13.15.01.016--Not Available
Restless legs syndrome17.02.07.008; 15.05.03.012--Not Available
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages